| MDL | - |
|---|---|
| Molecular Weight | 347.34 |
| Molecular Formula | C17H18FN3O4 |
| SMILES | O=C(C1=CC2=C(C(OC[C@H]([C@H](C)[C@@H]3F)NC3=O)=NC=C2)C=C1OC)N |
PF-06426779 is a potent and selective inhibitor of interleukin‑1 receptor associated kinase 4 (IRAK4) , with an IC 50 of 0.3 nM [1] .
|
IRAK4 0.3 nM (IC 50 ) |
PF-06426779 inhibits IRAK4, with an IC 50 of 12.7 nM in the peripheral blood mononuclear cells (PBMCs) assay [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 100 mg/mL ( 287.90 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.8790 mL | 14.3951 mL | 28.7902 mL |
| 5 mM | 0.5758 mL | 2.8790 mL | 5.7580 mL |
| 10 mM | 0.2879 mL | 1.4395 mL | 2.8790 mL |